Enfermedades Sistémicas de Base Autoinmune

Christiansen, SN; Rasmussen, SH; Pons, M; Michelsen, B; Glintborg, B; Gudbjornsson, B; Grondal, G; Vencovsky, J; Loft, AG; Rotar, Z; Pirkmajer, KP; Nissen, MJ; Baranova, J; Macfarlane, GJ; Jones, GT; Iannone, F; Caporali, R; Laas, K; Vorobjov, S; Di Giuseppe, D; Olofsson, T; Provan, SA; Fagerli, KM; Castrejon, I; Otero-Varela, L; van de Sande, M; van der Horst-bruinsma, I; Nordström, D; Kuusalo, L; Bernardes, M; Hetland, ML; Ostergaard, M; Ornbjerg, LM.

Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice

SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024; 65: Nº de citas: 4 [doi:10.1016/j.semarthrit.2024.152388]

Altabás-González, I; Pego-Reigosa, JM; Mouriño, C; Jiménez, N; Hernández-Martín, A; Casafont-Solé, I; Urguelles, JF; Román-Ivorra, JA; Navarro, MD; Galindo-Izquierdo, M; Salman-Monte, TC; Narváez, J; Vidal-Montal, P; García-Villanueva, MJ; Garrote-Corral, S; Blázquez-Cañamero, MA; Marras, C; Piqueras-García, M; Martínez-Barrio, J; Sánchez-Lucas, M; Cortés-Hernández, J; Penzo, E; Calvo-Alén, J; de Dios, JR; Rodríguez, B; Vasques-Rocha, M; Tomero, E; Menor-Almagro, R; Gandía, M; Gómez-Puerta, JA; Frade-Sosa, B; Ramos-Giráldez, C; Trapero-Pérez, C; Diez, E; Moriano, C; Muñoz-Jiménez, A; Rua-Figueroa, IJ.

Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients

RHEUMATOLOGY. 2024; 64(1): 276-282 Nº de citas: 3 [doi:10.1093/rheumatology/kead696]

Hellamand P; van de Sande MGH; Ørnbjerg LM; Klausch T; Eklund KK; Relas H; Santos MJ; Vieira-Sousa E; Loft AG; Glintborg B; Østergaard M; Lindström U; Wallman JK; Michelsen B; Fagerli KM; Castrejón I; Gudbjornsson B; Love TJ; Vencovský J; Nekvindová L; Rotar Ž; Tomšic M; Díaz-González F; Kenar G; Tugsal HY; Iannone F; Ramonda R; Codreanu C; Mogosan C; Nissen MJ; Möller B; Hetland ML; van der Horst-Bruinsma IE.

Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network.

ARTHRITIS & RHEUMATOLOGY. 2024; 76(4): 587-598 Nº de citas: 7 [doi:10.1002/art.42758]

Calvo-Gutiérrez, J; López-Medina, C; Otero-Varela, L; Escudero-Contreras, A; Ortega-Castro, R; Ladehesa-Pineda, L; Campos, C; Bernabeu-Gonzalvez, P; Pérez-Gómez, A; García-Dorta, A; Ruiz-Montesino, D; Pombo-Suarez, M; Ros-Vilamajo, I; Sánchez-Alonso, F; Castrejón, I.

Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry

ARTHRITIS RESEARCH & THERAPY. 2024; 26(1): Nº de citas: 2 [doi:10.1186/s13075-024-03287-9]

Rivera, J; Molina-Collada, J; Martinez-Barrio, J; Serrano-Benavente, B; Castrejon, I; Vallejo, MA; Alvaro-Gracia, JM.

Opioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center

BMC MUSCULOSKELETAL DISORDERS. 2024; 25(1): Nº de citas: 6 [doi:10.1186/s12891-024-07263-x]

Otín, T; Carmona, L; Rivera, J.

Patient-journey of fibromyalgia patients: A scoping review

Reumatologia Clinica. 2024; 20(2): 96-103 Nº de citas: 2 [doi:10.1016/j.reuma.2023.07.006]

Molina-Collada, J; Alonso, F; Otero, L; Bohórquez, C; Torné, CD; García, CP; Madrigal, JMB; Vela, P; Alvaro-Gracia, JM; Castrejón, I.

Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register

SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024; 64: 152341-152341 Nº de citas: 2 [doi:10.1016/j.semarthrit.2023.152341]

Molina-Collada, J; Domínguez-Alvaro, M; Melero-González, RB; Fernández-Fernández, E; Silva-Díaz, M; Valero, JA; González, I; Martín, JS; Narváez, J; Calvo, I; Mendizábal, J; Alcázar, LA; Loricera, J; Ruíz-Román, A; Moya, P; Cabañas, MT; Estrada, P; Prado-Galbarro, FJ; Castañeda, S; Blanco, R.

Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry

RHEUMATOLOGY. 2024; 64(2): 697-703 Nº de citas: 5 [doi:10.1093/rheumatology/keae042]

Alten, R; Nieto-Gonzalez, JC; Jacques, P; Montecucco, C; Moots, R; Radner, H; Vonkeman, HE; Heidenreich, S; Whichello, C; Krucien, N; Van Beneden, K.

What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment

Rmd Open. 2024; 10(1): [doi:10.1136/rmdopen-2023-003311]

Hellamand, P; van de Sande, M; Ornbjerg, LM; Klausch, T; Nurmohamed, MT; van Vollenhoven, RF; Nordström, D; Hokkanen, AM; Santos, MJ; Vieira-Sousa, E; Loft, AG; Glintborg, B; Hetland, ML; Lindström, U; Wallman, JK; Michelsen, B; Kristianslund, EK; Ciurea, A; Nissen, MS; Codreanu, C; Mogosan, C; Macfarlane, GJ; Rotariu, O; Rotar, Z; Tomsic, M; Castrejon, I; Otero-Varela, L; Gudbjornsson, B; Geirsson, AJ; Vencovsky, J; Pavelka, K; Gulle, S; Zengin, B; Iannone, F; Foti, R; Ostergaard, M; van der Horst-Bruinsma, I.

Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: results from the EuroSpA Research Collaboration Network

Rmd Open. 2023; 9(4): Nº de citas: 1 [doi:10.1136/rmdopen-2023-003325]

Membrive-Jiménez, C; Sánchez-Piedra, C; Martínez-González, O; García-González, J; Expósito-Pérez, L; Bohórquez-Heras, C; Campos-Fernández, C; Sanchez-Alonso, F; Cáliz-Cáliz, R; Castrejón-Fernández, I.

Safety and effectiveness of bDMARDs during pregnancy in patients with rheumatic diseases: Real-world data from the BIOBADASER registry

Reumatologia Clinica. 2023; 19(9): 500-506 Nº de citas: 2 [doi:10.1016/j.reuma.2023.02.003]

Linde, L; Ornbjerg, LM; Rasmussen, SH; Love, TJ; Loft, AG; Závada, J; Vencovsky, J; Laas, K; Nordstrom, D; Sokka-Isler, T; Gudbjornsson, B; Gröndal, G; Iannone, F; Ramonda, R; Hellamand, P; Kristianslund, EK; Kvien, TK; Rodrigues, AM; Santos, MJ; Codreanu, C; Rotar, Z; Tomsic, M; Castrejon, I; Díaz-Gonzáles, F; Di Giuseppe, D; Ljung, L; Nissen, MJ; Ciurea, A; Macfarlane, GJ; Heddle, M; Glintborg, B; Ostergaard, M; Hetland, ML.

Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration

ARTHRITIS RESEARCH & THERAPY. 2023; 25(1): Nº de citas: 2 [doi:10.1186/s13075-023-03184-7]

Nieto-Gonzalez, JC; Garulo, DC; Boteanu, A; Trives-Folguera, L; García-Fernández, A; Navarro, PG; Robledillo, JCL; Monteagudo-Saéz, I.

What to Expect When Systemic Treatment in Juvenile Idiopathic Arthritis Is Withdrawn?

JOURNAL OF RHEUMATOLOGY. 2023; 50(10): 1326-1332 Nº de citas: 2 [doi:10.3899/jrheum.2022-1305]

Michelsen, B; Ostergaard, M; Nissen, MJ; Ciurea, A; Moller, B; Ornbjerg, LM; Zavada, J; Glintborg, B; Macdonald, A; Laas, K; Nordstrom, D; Gudbjornsson, B; Iannone, F; Hellmand, P; Kvien, TK; Rodrigues, AM; Codreanu, C; Rotar, Z; Fernandez, IC; Wallman, JK; Vencovsky, J; Loft, AG; Heddle, M; Vorobjov, S; Hokkanen, AM; Groendal, G; Sebastiani, M; van de Sande, M; Kristianslund, EK; Santos, MJ; Mogosan, C; Tomsic, M; Diaz-Gonzalez, F; Di Giuseppe, D; Hetland, ML.

Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

Lancet Regional Health-Europe. 2023; 33: Nº de citas: 2 [doi:10.1016/j.lanepe.2023.100706]

Linde, L; Ornbjerg, LM; Brahe, CH; Wallman, JK; Di Giuseppe, D; Závada, J; Castrejon, I; Díaz-Gonzalez, F; Rotar, Z; Tomsic, M; Glintborg, B; Gudbjornsson, B; Geirsson, AJ; Michelsen, B; Kristianslund, EK; Santos, MJ; Barcelos, A; Nordström, D; Eklund, KK; Ciurea, A; Nissen, M; Akar, S; Hyldstrup, LH; Krogh, NS; Hetland, ML; Ostergaard, M.

Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching

RHEUMATOLOGY. 2023; 63(7): 1882-1892 Nº de citas: 8 [doi:10.1093/rheumatology/kead494]

Exposito, L; Sanchez-Piedra, C; Vela-Casasempere, P; Moreno-Ramos, MJ; Campos, C; Bohorquez, C; Manero, J; Calvo-Gutierrez, J; Rodriguez-Lozano, C; Ruiz-Montesino, D; Busquets, N; Garcia-Gonzalez, J; Castrejon, I; Alonso, F; Bustabad, S; Diaz-Gonzalez, F.

Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2023; 54(2): Nº de citas: 2 [doi:10.1111/eci.14095]

Mayordomo, L; Molina-Collada, J; Uson, J; Vivar, ML; Sturchio, GA; Corrales, A; Castillo-Gallego, C; Hernandez, F; Vicente-Rabaneda, EF; Nunez, FG; Gomez, I; Villar, M; Moragues, C; Corredor, D; de Miera, FJ; De Agustin, J; Molinero, MR; Sancho, JJ; Coronel, L; Huaranga, MA; Ruiz-Montesino, M; Collado-Ramos, P; Penas,M; Miguelez, R; Fernandez, E; Valera-Ribera, C; Naredo, E; ECOSER Grp.

Ultrasonography in rheumatology: time to learn from patient views

CLINICAL RHEUMATOLOGY. 2023; 42(12): 3341-3350 [doi:10.1007/s10067-023-06757-8]

Dejaco, C; Ramiro, S; Bond, M; Bosch, P; Ponte, C; Mackie, SL; Bley, TA; Blockmans, D; Brolin, S; Bolek, EC; Cassie, R; Cid, MC; Molina-Collada, J; Dasgupta, B; Nielsen, BD; De Miguel, E; Direskeneli, H; Duftner, C; Hocevar, A; Molto, A; Schafer, VS; Seitz, L; Slart, RHJA; Schmidt, WA.

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update

ANNALS OF THE RHEUMATIC DISEASES. 2023; 83(6): 741-751 Nº de citas: 171 [doi:10.1136/ard-2023-224543]